Please use this identifier to cite or link to this item:
Title: Letter: choosing between ustekinumab and vedolizumab in anti-TNF refractory Crohn's disease-the devil is in the detail.
Austin Authors: Srinivasan, Ashish ;De Cruz, Peter P ;van Langenberg, Daniel R
Affiliation: Department of Gastroenterology, Eastern Health, Melbourne, Victoria, Australia
Gastroenterology and Hepatology
Medicine (University of Melbourne)
Department of Medicine, Monash University, Melbourne, Victoria, Australia
Issue Date: Aug-2020
Publication information: Alimentary Pharmacology & Therapeutics 2020; 52(3): 561-562
DOI: 10.1111/apt.15862
ORCID: 0000-0001-5952-1570
PubMed URL: 32656826
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Dec 2, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.